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Coexisting coronary artery disease and signiﬁcant heart valve disease represent a
considerable risk factor in patients undergoing pulmonary resection. The possibility to
perform concomitant (simultaneous) heart and lung surgery could be a good option for
many patients.
In the presented case report, the intervention was performed on two valves, triple
coronary artery bypass and pulmonary resection, which has not been published in
literature to date.
A 68-year-old woman with coronary artery disease, aortic valve stenosis, tricuspid valve
regurgitation and pulmonary disease (malignant pathology) presented with triple vessel
disease, moderate aortic valve stenosis, severe tricuspid regurgitation and tumorous
inﬁltration in the upper lobe of the left lung. She underwent combined heart and
pulmonary surgery-left upper lobectomy, aortic valve replacement, tricuspid valve repair
and coronary artery bypass surgery. On the eight day of surgery, she was discharged. She
continues to do well on follow-up.
Simultaneous cardiac surgery and pulmonary resection for malignancy become almost
standard treatment of patients who require heart and lung surgery. The most often
approach is midline sternotomy that enables a comfortable cardiac intervention as well as
an acceptable access to lungs. The left lower lobectomy remains an exception, in which
pulmonary resection during extracorporeal circulation (ECC) is more often an option of left
thoracotomy. If the use of ECC is inevitable, some authors prefer pulmonary resection
before starting up ECC if the location of the neoplasm does not require resection during
ECC.
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Table 2 – Explanation of abbreviations.
CABG Coronary Artery Bypass Grafting
CAD Coronary Artery Disease
ECC Extracorporeal Circulation
X-clamp Cross aortic clamp
SJM St. Jude Medical, St. Paul, Minnesota, USA
Off-pump Cardiac procedure performed without using of
Extracorporeal Circulation
AVR Aortic Valve Replacement
STEMI ST Segment Elevation Myocardial Infarction
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Coexistence of heart pathology represents a considerable risk
factor in patients undergoing pulmonary resection. Despite
the fact that symptoms in those patients coincide, major
centers present only a 0.5% rate of patients requiring both
surgical interventions [1]. Moreover, the rate of e.g. smokers
in this group of patients is according to published literature
merely 54% in comparison to 49% in patients with lung tumor
without a cardiac ﬁnding [2,3]. On the other side, the rate of
patients undergoing thoracotomy and requiring a cardiac
surgery performs up to 5% [4].
The ﬁrst paper presenting simultaneous cardiac surgery
for coronary artery disease and pulmonary resection for lung
cancer by the authors Davydov et al. dates back to 1978 [5].
To the present day, numerous case reports have been
published as well as small clinical groups presenting simul-
taneous cardiac and pulmonary surgery. However, explicit
management of such patients has not been determined yet. If
the pulmonary resection in patients with coronary disease is
indicated, four speciﬁc approaches are presented in litera-
ture. The ﬁrst is resection of the lung in advance of cardiac
intervention – two stage procedure. The second is percuta-
neous coronary intervention (PCI) in case of coronary artery
disease (CAD) followed by pulmonary resection. However,
this management is not applicable if simultaneous valve
surgery is indicated. The third approach is heart procedure
and subsequent lung surgery – two stage procedure. The
fourth alternative is simultaneous cardiac operation and lung
– one stage procedure (Tables 1 and 2) [1].
The ﬁrst option is possible only in patients with an
appropriate cardiac status, in who cardiac intervention
is not inevitable. Primary PCI in advance of lung intervention
is eligible merely for an appropriate coronary angiography
without a heart valves pathology. Moreover, an increased risk
of in-stent thrombosis at the time of lung surgery six weeks
after the PCI has been presented in literature [6]. Some
authors conﬁrm an increased risk and they suggest to post-
pone pulmonary resection up to 3 months, which could be
almost inacceptable regarding the oncological status of
patient [7].
Therefore these two procedures are not applicable in the
majority of patients. The choice of a two-stage operation,
whereas cardiac surgery is carried out in advance, is suitable
in each patient. Nevertheless, it carries a higher risk for theTable 1 – Comparison of advantages and disadvantages of var
pulmonary cancer.
(+)
LS-CABG/VR Timely oncological intervention
PTCA-LS Reliability
CABG/VR-LS Lower bleeding risk in comparison to
simultaneous performances
CABG/VR+LS Lower load with one anesthesia less pain with
one accesspatient due to two anesthesiological and surgical accesses,
which is obviously more painful, and undoubtly, worsening
of cost-effectiveness is also present. An advantage of thor-
acotomy is a better accessibility of lymphatic nodes in the
posterior mediastinum as well as a better accessibility of the
left lower lobectomy or the left-side pulmectomy, which
makes this surgical access partly preferable [8]. If a midline
sternotomy is performed, exploration of posterior mediasti-
num is often inevitable in this location [1,9]. The present-day
view of essential total lymph nodes dissection is yet con-
troversial with regard to prolonged operation time and
increased of morbidity [2]. The fourth possibility of perform-
ing both cardiac and lung interventions simultaneously
represents an appropriate method for many patients. The
opportunity of option if either sternotomy or thoracotomy as
well as the timing of surgeries (and necessity of ECC) provides
a wide spectrum of methods and individualization of the
procedure with respect to the needs of a speciﬁc patient.
Heparinization with a higher risk of bleeding in the bed after
lung surgery could be a possible complication [10]. Pavia et al.
present a paper with a total of 189 patients with cardiac
surgery in advance and followed by pulmonary resection
(two-stage procedure) as the most eligible method. The
second most frequently used approach was combined cardiac
and lung surgery (one-stage procedure) [11].Case report
A case report of a 68-year-old woman with a personal history
of hypertension and autoimmune thyroiditis with struma
nodosa is presented. The patient was hospitalized in a regional
hospital for subacute non-ST elevation myocardial infarction
and transferred to our institution. Cardiac catheterizationying timing of intervention for coronary artery disease and
()
High preoperation and early postoperative risk at thoracic
operation
Reliability necessity to postpone thoracic surgery 6 weeks to
3 months, necessity of adequate cardiac ﬁnding
Load of double anesthesia, two surgical wounds, short-
dated delay of thoracic onco-logical operation, ﬁnancial
demands
Access via sternotomy with necessity of left lower
lobectomy, bleeding risk at heparinization
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cardiographic ﬁndings were moderate stenosis of aortic valve
withmean pressure gradient of 25mmHg and severe tricuspid
valve regurgitation. Pre-operative plain X-ray of thorax showed
a non-homogenous overshadow of 4 cm in diameter in the left
pulmonary upper lobe in the area of the second rib, linked to
the left hilus (Fig. 1). Subsequently, a CT scan conﬁrmed
assumed tumorous inﬁltration in the upper left lobe with
pleural inﬁltration but without mediastinal or other lymphatic
involvement yet. Bronchoscopy was carried out, but brush
cytology samples were negative. Considering the ﬁnding, we
decided on combined cardiac surgery with per-operative
histological examination of the lung malignancy and, in the
case of positive malignant ﬁnding, simultaneous pulmonary
resection.
58 days after the ﬁrst symptoms of subacute non-STEMI,
the patient underwent surgical operation. Standard midline
sternotomy had been done. In the ﬁrst part of operation,
histological samples of the lung tumor have been harvested
and subsequent pathological screening has revealed a low-
differentiated adenocarcinoma. Referring to that conclusion,
left upper lobectomy was accomplished. Next an EEC was
established and heart was arrested by using an antegrade
intermittent cold blood cardioplegic solution. Triple coronary
artery bypass on left anterior descending, marginal and right
coronary artery was done using autologous vein grafts. Aortic
valve was replaced by a biological prosthesis Trifecta (St. Jude
Medical, St. Paul, Minnesota, USA) in size 21 and tricuspid
annuloplasty with Tailor ring (St. Jude Medical, St. Paul,
Minnesota, USA) in size 29 has been performed. After remov-
ing of X-clamp, three proximal anastomoses were performed.
The early post-operative period was uneventful. The ﬁnal
outcome of histological examination showed the presence of
unifocal tumor – adenocarcinoma mixed subtype grade 3
with local penetration into visceral pleura. All resection
margins as well as lymphatic nodes were negative to pre-
sence of tumor cells. On the eight day, the patient was
discharged and she continues to do well on follow-up.Fig. 1 – Plain pre-operative X-ray of our patient's chest
showing circle overshadow in upper left lobe (black arrow).Discussion
Simultaneous operations perform a parallel surgical inter-
vention in two organs for at least two different diseases. In
certain cases, cardiac surgical intervention and pulmonary
resection are indicated for only one malignant pulmonary
process metastasizing into the heart [12]. At present, there
have also been described simultaneous combinations of
other than thoracic intervention with cardiac surgery, as
e.g. resection of the intestine [13]. Major apprehension of
simultaneous cardiac and oncological surgical interventions
aims to the necessity of using heparinization for ECC which is
followed by a higher risk of bleeding complications. On
the other hand, higher blood losses have been described in
separate thoracic surgical interventions as well, however,
in the most cases sufﬁcient coagulation status allows their
conservative management [14]. Brutel et al. describe the
occurrence of hemorrhagic complications requiring surgical
revision in 8.8% using ECC [10]. Dyskiewicza et al. have
published two studies including utilization of a method
without using ECC (off-pump) in a combined surgery on the
heart and lungs. While they report on occurrence of hemor-
rhagic complications in 7.7%, in a study from the year 2008,
the hemorrhagic complication with the need of surgical
reexploration does not occur any more [1,4]. In general, there
is an endorsement of a maximum possible effort of the
method without using ECC in combined surgery on the heart
and lungs [1,4,15]. Summarizing the reports including assem-
blies of patients undergoing a combined surgery on the heart
and lungs, ECC was used in 72.5% and off-pump method in
27.5%, while in 81.1% lung surgery was combined only with
coronary artery bypass grafting for CAD without intervention
on the valves. In 8% the aortic valve was operated on, in 3.4%
the mitral valve, in 2% combined surgery was done concern-
ing the aortic valve and coronary arteries, in 2.7% the mitral
valve and coronary arteries and in 2.7% another cardiac
intervention was carried out [1,2,4,5,10,15–19]. In the pre-
sented case report, the intervention was performed on two
valves, triple coronary artery bypass and pulmonary resec-
tion, which has not been published to date yet. The most
frequently described postoperative complication after a
simultaneous operation are supraventricular arythmias in
10.9%, pneumonia in 6.4%, pulmonary atelectases in 4.1%,
pneumotorax in 1.4% and both air-leak and respiratory
insufﬁciency in 0.5% [1,2,4,5,10,15–19]. In our case report, no
postoperative complication has been found in the patient.
If the using of ECC is inevitable, it is important to answer the
question of timing ECC and resection of the lung. On the basis
of literature we learn that in 73.8% resections had been done
before establishing ECC, while during ECC resection was
performed in 26.2% only. No lung resection after veaning
the ECC has been reported [2,16,19]. Priority of the lung
resection in advance of ECC establishment may be explained
by a better coagulative condition as well as by shortening the
duration of ECC. Using of ECC during lung resection has been
selected due to localization of the malignant process on the
lungs, whereas by choosing sternotomy, the left lower
lobectomy is difﬁcult to carry out [16,19]. Further important
angle of view is the inﬂuence of ECC on dissemination of
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with progression of hematogeneous spread of tumor cells
[20]. It may cause interim suppression of the immune system,
which makes the metastatic process easier. In literature there
are a few clinical studies presenting inﬂuences of ECC on
malignity and long-term survival. Hasegawa et al. have
published a work presenting a considerable cell dissemina-
tion of thyroid papillary carcinoma whereas they demon-
strate that in oncological patients a retrograde use of
the aspirated blood is not recommended as in cardiac
surgeries [21]. However, further work reports that the use of
ECC does not inﬂuence the 5-year-long survival of oncological
patients [22]. Other authors conclude in their studies that the
5-year-long survival is inﬂuenced only by the phase of the
oncological process and not by using or not using either
reapplication of aspirated blood or ECC in general [5]. Midline
sternotomy is a preferred surgical approach in cardiac sur-
gery. It could be used in thoracic surgery as well, predomi-
nantely if bilateral intervention is necessary [23]. The use of
sternotomy in resection of the lung is connected with a
disadvantageous access into the posterior mediastinum and
left lower pulmonary region. With regard to the fact that
radical lymphadenectomy has been abandoned at the treat-
ment of lung cancer and the left lower lobectomy is possible
while on ECC, the majority of authors incline to use sternot-
omy as method of choice. In spite of the fact that this
approach is not ideal, is becoming almost worldwide. On
the other side, there can be found papers selecting thoracot-
omy for combined simultaneous surgery on the heart and
lungs. It is appropriate to a for patients with coronary artery
disease when coronary bypass could be accomplished off-
pump [9,24].Conclusion
Simultaneous cardiac surgery and pulmonary resection for
malignancy become in a present almost standards in treat-
ment of patients requiring cardiac and lung intervention. The
most often surgical approach is midline sternotomy that
enables a comfortable cardiac intervention as well as an
adequate access to almost all lung segments. The left lower
lobectomy remains an exception, which is possible either
during ECC or without ECC via left thoracotomy. Most authors
prefer, if allowed by cardiac intervention and status, the use
of the off-pump method. If using of ECC is essential, more
authors prefer lung resection in advance of ECC establish-
ment if the location of the malignancy does not require
resection within ECC period.Conﬂict of interests
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